This KB Home Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Tuesday

Generate Biomedicines, Inc. +0.66%
KB Home -3.14%
Smith Douglas Homes Corp. Class A -0.04%
Solventum Corporation -0.63%

Generate Biomedicines, Inc.

GENB

12.18

+0.66%

KB Home

KBH

49.73

-3.14%

Smith Douglas Homes Corp. Class A

SDHC

13.70

-0.04%

Solventum Corporation

SOLV

62.85

-0.63%

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

  • Citizens analyst James McCanless initiated coverage on KB Home (NYSE:KBH) with a Market Outperform rating and announced a price target of $77. KB Home shares closed at $53.19 on Monday. See how other analysts view this stock.
  • Rothschild & Co analyst Jackson Philips initiated coverage on Solventum Corp (NYSE:SOLV) with a Sell rating and announced a price target of $60. Solventum shares closed at $65.69 on Monday. See how other analysts view this stock.
  • Citizens analyst James McCanless initiated coverage on Smith Douglas Homes Corp (NYSE:SDHC) with a Market Perform rating. Smith Douglas Homes shares closed at $12.13 on Monday. See how other analysts view this stock.
  • Guggenheim analyst Seamus Fernandez initiated coverage on Generate Biomedicines Inc (NASDAQ:GENB) with a Buy rating and announced a price target of $30. Generate Biomedicines shares closed at $12.52 on Monday. See how other analysts view this stock.

Considering buying KBH stock? Here’s what analysts think:

Photo via Shutterstock

This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.